Qingdao Haier Biomedical Co Ltd
SSE:688139
Qingdao Haier Biomedical Co Ltd
SSE:688139
Price:
34.03
CNY
5%
Market Closed
Market Cap:
¥10.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Qingdao Haier Biomedical Co Ltd
SSE:688139
|
CN |
|
Mastek Ltd
NSE:MASTEK
|
IN |
|
Axiom Properties Ltd
ASX:AXI
|
AU |
|
Sincere Co Ltd
TSE:7782
|
JP |
|
I
|
iLearningEngines Inc
OTC:AILEQ
|
US |
|
Maan Aluminium Ltd
NSE:MAANALU
|
IN |
|
Korn Ferry
NYSE:KFY
|
US |
|
E
|
Erin Energy Corp
OTC:ERINQ
|
US |
|
Z
|
Zhejiang Xinao Textiles Inc
SSE:603889
|
CN |
Income Statement
Earnings Waterfall
Qingdao Haier Biomedical Co Ltd
Qingdao Haier Biomedical Co Ltd
Income Statement
Qingdao Haier Biomedical Co Ltd
Qingdao Haier Biomedical Co Ltd
Currency: CNY
| Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||
| Interest Expense |
14
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
4
|
4
|
3
|
3
|
3
|
3
|
4
|
0
|
0
|
4
|
|
| Revenue |
952
N/A
|
1 013
+6%
|
1 078
+6%
|
1 166
+8%
|
1 266
+9%
|
1 402
+11%
|
1 549
+10%
|
1 735
+12%
|
1 941
+12%
|
2 126
+10%
|
2 276
+7%
|
2 466
+8%
|
2 681
+9%
|
2 864
+7%
|
2 987
+4%
|
2 867
-4%
|
2 615
-9%
|
2 281
-13%
|
2 281
+0%
|
2 234
-2%
|
2 237
+0%
|
2 284
+2%
|
2 286
+0%
|
2 256
-1%
|
2 263
+0%
|
2 329
+3%
|
|
| Gross Profit | |||||||||||||||||||||||||||
| Cost of Revenue |
(454)
|
(471)
|
(513)
|
(567)
|
(625)
|
(696)
|
(781)
|
(873)
|
(975)
|
(1 061)
|
(1 149)
|
(1 243)
|
(1 425)
|
(1 490)
|
(1 566)
|
(1 501)
|
(1 309)
|
(1 128)
|
(1 156)
|
(1 165)
|
(1 167)
|
(1 190)
|
(1 222)
|
(1 221)
|
(1 238)
|
(1 247)
|
|
| Gross Profit |
498
N/A
|
542
+9%
|
565
+4%
|
599
+6%
|
641
+7%
|
707
+10%
|
768
+9%
|
863
+12%
|
965
+12%
|
1 065
+10%
|
1 126
+6%
|
1 223
+9%
|
1 256
+3%
|
1 374
+9%
|
1 421
+3%
|
1 366
-4%
|
1 306
-4%
|
1 153
-12%
|
1 125
-2%
|
1 069
-5%
|
1 070
+0%
|
1 094
+2%
|
1 064
-3%
|
1 035
-3%
|
1 025
-1%
|
1 082
+5%
|
|
| Operating Income | |||||||||||||||||||||||||||
| Operating Expenses |
(287)
|
(304)
|
(339)
|
(330)
|
(338)
|
(361)
|
(419)
|
(462)
|
(528)
|
(599)
|
(633)
|
(692)
|
(700)
|
(787)
|
(793)
|
(817)
|
(836)
|
(816)
|
(802)
|
(763)
|
(761)
|
(766)
|
(765)
|
(806)
|
(825)
|
(869)
|
|
| Selling, General & Administrative |
(201)
|
(211)
|
(213)
|
(216)
|
(214)
|
(246)
|
(271)
|
(294)
|
(343)
|
(373)
|
(412)
|
(459)
|
(462)
|
(506)
|
(528)
|
(547)
|
(553)
|
(493)
|
(528)
|
(498)
|
(502)
|
(443)
|
(504)
|
(533)
|
(542)
|
(519)
|
|
| Research & Development |
(105)
|
(119)
|
(126)
|
(132)
|
(147)
|
(151)
|
(166)
|
(185)
|
(217)
|
(236)
|
(263)
|
(278)
|
(274)
|
(292)
|
(304)
|
(316)
|
(324)
|
(314)
|
(318)
|
(307)
|
(302)
|
(299)
|
(309)
|
(323)
|
(325)
|
(316)
|
|
| Depreciation & Amortization |
0
|
(3)
|
0
|
0
|
0
|
(7)
|
0
|
0
|
0
|
(28)
|
0
|
0
|
0
|
(32)
|
0
|
0
|
0
|
(60)
|
0
|
0
|
0
|
(75)
|
0
|
0
|
0
|
(77)
|
|
| Other Operating Expenses |
21
|
28
|
(0)
|
19
|
23
|
43
|
17
|
16
|
31
|
38
|
42
|
44
|
36
|
43
|
39
|
47
|
41
|
51
|
44
|
42
|
43
|
51
|
49
|
50
|
43
|
42
|
|
| Operating Income |
211
N/A
|
238
+13%
|
226
-5%
|
270
+19%
|
302
+12%
|
346
+14%
|
348
+1%
|
400
+15%
|
438
+9%
|
466
+6%
|
493
+6%
|
531
+8%
|
556
+5%
|
587
+6%
|
628
+7%
|
549
-13%
|
470
-14%
|
337
-28%
|
323
-4%
|
306
-5%
|
309
+1%
|
327
+6%
|
299
-9%
|
229
-23%
|
201
-12%
|
212
+6%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||
| Interest Income Expense |
(6)
|
(1)
|
35
|
47
|
91
|
62
|
478
|
494
|
467
|
86
|
115
|
121
|
133
|
89
|
76
|
108
|
89
|
76
|
120
|
77
|
75
|
74
|
75
|
73
|
72
|
53
|
|
| Non-Reccuring Items |
(9)
|
(27)
|
0
|
(22)
|
(22)
|
15
|
0
|
0
|
0
|
410
|
0
|
0
|
1
|
(0)
|
0
|
(2)
|
(3)
|
25
|
(2)
|
0
|
0
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
2
|
1
|
(5)
|
(7)
|
(10)
|
2
|
(3)
|
(1)
|
2
|
(0)
|
0
|
1
|
1
|
0
|
(1)
|
(6)
|
(6)
|
(2)
|
(4)
|
3
|
1
|
2
|
1
|
(1)
|
(1)
|
(0)
|
|
| Pre-Tax Income |
199
N/A
|
211
+6%
|
257
+22%
|
288
+12%
|
361
+25%
|
424
+18%
|
823
+94%
|
893
+9%
|
906
+1%
|
961
+6%
|
608
-37%
|
652
+7%
|
690
+6%
|
675
-2%
|
703
+4%
|
649
-8%
|
551
-15%
|
434
-21%
|
437
+1%
|
386
-12%
|
385
0%
|
402
+4%
|
373
-7%
|
299
-20%
|
270
-10%
|
265
-2%
|
|
| Net Income | |||||||||||||||||||||||||||
| Tax Provision |
(25)
|
(28)
|
(33)
|
(32)
|
(37)
|
(40)
|
(88)
|
(90)
|
(96)
|
(112)
|
(65)
|
(75)
|
(77)
|
(63)
|
(66)
|
(55)
|
(38)
|
(22)
|
(23)
|
(19)
|
(20)
|
(21)
|
(17)
|
(10)
|
(6)
|
(10)
|
|
| Income from Continuing Operations |
174
|
183
|
224
|
256
|
324
|
384
|
735
|
802
|
810
|
849
|
543
|
577
|
613
|
612
|
638
|
594
|
513
|
412
|
414
|
367
|
365
|
381
|
355
|
289
|
264
|
255
|
|
| Income to Minority Interest |
(1)
|
(1)
|
(1)
|
(2)
|
(3)
|
(3)
|
(4)
|
(3)
|
(3)
|
(4)
|
(4)
|
(5)
|
(5)
|
(11)
|
(13)
|
(15)
|
(17)
|
(6)
|
(8)
|
(5)
|
(7)
|
(14)
|
(16)
|
(14)
|
(8)
|
(4)
|
|
| Net Income (Common) |
173
N/A
|
182
+5%
|
223
+22%
|
254
+14%
|
321
+27%
|
381
+19%
|
732
+92%
|
799
+9%
|
807
+1%
|
845
+5%
|
539
-36%
|
573
+6%
|
608
+6%
|
601
-1%
|
625
+4%
|
579
-7%
|
497
-14%
|
406
-18%
|
406
+0%
|
362
-11%
|
358
-1%
|
367
+2%
|
339
-7%
|
275
-19%
|
256
-7%
|
251
-2%
|
|
| EPS (Diluted) |
0.74
N/A
|
0.73
-1%
|
0.7
-4%
|
0.79
+13%
|
1.01
+28%
|
1.17
+16%
|
2.3
+97%
|
2.52
+10%
|
2.54
+1%
|
2.66
+5%
|
1.7
-36%
|
1.8
+6%
|
1.92
+7%
|
1.9
-1%
|
1.97
+4%
|
1.82
-8%
|
1.56
-14%
|
1.28
-18%
|
1.28
N/A
|
1.14
-11%
|
1.13
-1%
|
1.16
+3%
|
1.07
-8%
|
0.87
-19%
|
0.81
-7%
|
0.8
-1%
|
|
Switch to:
Switch to:
See Also
Discover More
